Vision is a key function to sense the world and perform complex tasks, with a high sensitivity and a strong reliability, given the fact that most of its input is noisy, changing and ambiguous. Better understanding biological vision will have a strong scientific, medical, societal and technological impact in the near future.
One particular focus of our team is visual impairment. Visual impairment affects some 285 million people in the world, mostly in developed countries: 85% have low vision, i.e., have remaining sight, and 15% are totally blind. It is predicted that the prevalence of visual disabilities will increase markedly during the next 20 years, owing largely to the aging.
In this context, the goal of the Biovision team is to investigate new solutions to help vision impaired people, through fundamental research as well as innovative technological developments.
We have two main axes of research:
- Axis 1 focuses on the development of high tech vision aid systems for low vision patients.,
- Axis 2 focus on the precise modeling of the visual system for normal and dystrophic conditions, targeting applications for blind patients.
These axes are developed in strong synergy, involving a large network of national and international collaborators with neuroscientists, physicians, and modelers.